23andMe Holding Co. ( ME) - Key Metrics
Stock symbol ME is outdated, potentially delisted? Maybe it is available on other exchange?
ME Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2024Q2 | $1.73 | -$2.32 | -$2.34 | -$2.29 |
| 2024Q1 | $1.63 | -$2.80 | -$1.75 | -$1.80 |
| 2023Q4 | $2.64 | -$8.59 | -$0.70 | -$0.79 |
| 2023Q3 | $1.86 | -$11.56 | -$0.50 | -$0.59 |
| 2023Q2 | $2.11 | -$3.17 | -$2.41 | -$2.52 |
ME Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2024Q2 | ? | -0.75 |
| 2024Q1 | ? | -0.67 |
| 2023Q4 | ? | -0.31 |
| 2023Q3 | ? | -0.40 |
| 2023Q2 | ? | -1.54 |
ME
Price: $0.61
52 week price:
Earnings Per Share: -17.39 USD
P/E Ratio: -0.03
Exchange: NCM
Sector: Healthcare
Industry: Diagnostics & Research
Country: United States
Volume: 1.6 million
Market Capitalization: 13.3 million